Clinical trial
A 12-week Study to Compare the Effects of Vildagliptin Versus Glibenclamide on Glycemic Variability After a Sub Maximal Exercise Test in Patients With Type 2 Diabetes Inadequately Controlled With Metformin.
NCT01867502 is registered in ClinicalTrials.gov with Hospital de Clinicas de Porto Alegre as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A 12-week Study to Compare the Effects of Vildagliptin Versus Glibenclamide on Glycemic Variability After a Sub Maximal Exercise Test in Patients With Type 2 Diabetes Inadequately Controlled With Metformin.
- Lead sponsor
- Hospital de Clinicas de Porto Alegre
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- April 30, 2014
- Completion date
- August 31, 2015
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes mellitus, type 2, diabetic blood glucose monitoring, exercise, hypoglycemic agents